TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

Juno Therapeutics Inc (NASDAQ:JUNO) Investor Lawsuit Against Acquisition By Celgene Corporation Filed

  • If you purchased shares of Juno Therapeutics Inc (NASDAQ:JUNO), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

February 26, 2018 - The case was voluntarily dismissed. February 13, 2018 - An investor, who currently holds shares of Juno Therapeutics Inc (NASDAQ:JUNO), filed a lawsuit in effort to halt the proposed takeover of Juno Therapeutics Inc. by Celgene Corporation for $87 per share. Seattle, WA based Juno Therapeutics Inc is a biopharmaceutical company, which is focused on developing cell...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)